$126.28-5.88 (-4.45%)
Albemarle Corporation provides energy storage solutions worldwide.
Albemarle Corporation in the Basic Materials sector is trading at $126.28 with a market capitalization of $16.2B. Wall Street consensus targets $172.56 (20 analysts), implying a +36.7% move over the next 12 months. The stock is currently 43% below its 52-week high of $221.00, remaining 19.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.74B↑ | $1.43B | $1.43B↑ | $1.31B↓ | $1.33B |
| Gross Profit | $590.30M↑ | $500.97M↑ | $197.93M↑ | $117.61M↓ | $196.88M |
| Operating Income | $460.28M↑ | $354.39M↑ | $30.25M↑ | -$33.64M↓ | $51.98M |
| Net Income | $479.96M↑ | $319.09M↑ | -$414.18M↓ | -$160.69M↓ | $22.90M |
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and l...

Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

The leading global lithium producer Albemarle Corp. has named BHP Group Limited’s Chief Commercial Officer Ragnar “Rag” Udd as its next CEO. Udd will take over on Feb. 1, 2027, succeeding Kent Masters, who will become executive chairman at the...

Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ALB and SQM are ramping capacity and expanding output as EV and storage demand accelerates.

ALB's $3.2B liquidity, surging cash flow and rising lithium prices could fuel stronger shareholder returns.
Academic risk and quality models computed from ALB's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 56.6% reading.
Fama-French 5-factor market beta. The five factors explain 18% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-04.